CN Patent

CN101663022A — 局部药物制剂

Assigned to FUTURA MEDICAL DEVELOPMENTS Ltd · Expires 2010-03-03 · 16y expired

What this patent protects

用于局部施用NSAID的组合物包含载体系统配制的NSAID溶液或混悬液，所述载体系统包含多元醇、乙二醇醚和高级脂肪酸酯并且在环境温度下以单相存在。所述NSAID可以是双氯芬酸类，例如双氯芬酸。所述多元醇可以是二醇，例如异丙二醇，所述乙二醇醚可以是二乙二醇醚，例如二乙二醇单乙基醚。

USPTO Abstract

用于局部施用NSAID的组合物包含载体系统配制的NSAID溶液或混悬液，所述载体系统包含多元醇、乙二醇醚和高级脂肪酸酯并且在环境温度下以单相存在。所述NSAID可以是双氯芬酸类，例如双氯芬酸。所述多元醇可以是二醇，例如异丙二醇，所述乙二醇醚可以是二乙二醇醚，例如二乙二醇单乙基醚。

Drugs covered by this patent

Patent Metadata

Patent number
CN101663022A
Jurisdiction
CN
Classification
—
Expires
2010-03-03
Drug substance claim
No
Drug product claim
No
Assignee
FUTURA MEDICAL DEVELOPMENTS Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.